Results 51 to 60 of about 48,922 (288)

Can performance-based financing improve efficiency of health centers in Ethiopia? A Malmquist Productivity Index analysis

open access: yesBMC Health Services Research
Introduction The Ethiopian government has introduced several healthcare financing reforms intending to improve efficiency. Piloting implementation of performance-based financing is one of these actions.
Mideksa Adugna   +2 more
doaj   +1 more source

From oil reliance to financial resilience: have economic sanctions made OPEC countries’ healthcare financing independent from oil?

open access: yesCogent Business & Management
The OPEC governments mainly financed their budgets by relying on oil production, similar to many other governments globally. However, the world’s ongoing economic development, changes in countries’ political relationships, and exchange of sanctions could
Salem Al Mustanyir
doaj   +1 more source

Sources of health care financing in Poland and Germany

open access: yesPrawo Budżetowe Państwa i Samorządu, 2018
This paper focuses on public sources of a healthcare financing in Poland and in Germany. These systems are based primarily on the health insurance contributions. In Poland and in Germany a healthcare is also financed from state budgets. Author identified
Paweł Lenio
doaj   +1 more source

The review of the foreign experience on the financing of innovative medical technologies

open access: yesФармакоэкономика, 2020
The article presents a review of the foreign approaches to the mechanisms of financing of medical help and innovative medical technologies with the description of the implemented financial mechanisms of stimulation of innovations in foreign systems of ...
V. V. Omelyanovskiy   +4 more
doaj   +1 more source

Accelerated Reforms in Healthcare Financing: The Need to Scale up Private Sector Participation in Nigeria [PDF]

open access: yesInternational Journal of Health Policy and Management, 2014
The health sector, a foremost service sector in Nigeria, faces a number of challenges; primarily, the persistent under-funding of the health sector by the Nigerian government as evidence reveals low allocations to the health sector and poor health system
Ufuoma John Ejughemre
doaj   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Self-Rated Health Trajectories among Married Americans: Do Disparities Persist over 20 Years?

open access: yesJournal of Aging Research, 2018
The purpose of this study is to understand self-rated health (SRH) trajectories by social location (race/ethnicity by gender by social class) among married individuals in the United States. We estimate multilevel models of SRH using six observations from
Terceira A. Berdahl, Julia McQuillan
doaj   +1 more source

Healthcare disparities and models for change. [PDF]

open access: yes, 2004
With Healthy People 2010 making the goal of eliminating health disparities a national priority, policymakers, researchers, medical centers, managed care organizations (MCOs), and advocacy organizations have been called on to move beyond the historic ...
Bengen-Seltzer, Barbara   +2 more
core   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

open access: yesMolecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy